Metformin Regulates the Expression of CD133 Through the AMPK-CEBPβ Pathway in Hepatocellular Carcinoma Cell Lines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Metformin Regulates the Expression of CD133 Through the AMPK-CEBPβ Pathway in Hepatocellular Carcinoma Cell Lines

Published:2019-06 Issue:6 Volume:21 Page:545-556
ISSN:1476-5586
Container-title:Neoplasia
language:en
Short-container-title:Neoplasia

Author:

Maehara Osamu,Ohnishi Shunsuke,Asano Ayaka,Suda Goki,Natsuizaka Mitsuteru,Nakagawa Koji,Kobayashi Masanobu,Sakamoto Naoya,Takeda Hiroshi

Funder

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Cancer Research

Reference50 articles.

1. Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivo;Cai;Oncol Rep,2013

2. Attenuation of CD4(+)CD25(+) regulatory T cells in the tumor microenvironment by metformin, a type 2 diabetes drug;Kunisada;EBioMedicine,2017

3. The cancer stem cell: premises, promises and challenges;Clevers;Nat Med,2011

4. Cancer stem cells: current status and evolving complexities;Visvader;Cell Stem Cell,2012

5. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity;Yin;Int J Cancer,2007

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A randomized controlled study of neoadjuvant metformin with chemotherapy in nondiabetic breast cancer women: The METNEO study;British Journal of Clinical Pharmacology;2024-08-07

2. Traditional Chinese Medicine and renal regeneration: experimental evidence and future perspectives;Chinese Medicine;2024-06-03

3. Nanomedicine Based Therapies Against Cancer Stem Cells;Recent Progress in Pharmaceutical Nanobiotechnology: A Medical Perspective;2023-12-27

4. The strategies to cure cancer patients by eradicating cancer stem-like cells;Molecular Cancer;2023-10-18

5. Analysis of differential membrane proteins related to matrix stiffness-mediated metformin resistance in hepatocellular carcinoma cells;Proteome Science;2023-09-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3